LONDON -- The share price movements of�Ocado Group� (LSE: OCDO ) have always been entertaining, but events of this past week have been fairly remarkable, even by its standards.
The online grocer is one of the stocks that investors seem to love to hate. Currently, it's one of the most widely shorted shares on the market, with a short interest of some 16%, according to publicly disclosed holdings.
After trading as low as 170 pence at the end of last week, the shares jumped 12% on Wednesday. At one stage on Friday morning, they had leapt a further 20% to just under 250 pence, before slipping back somewhat.
A "short squeeze" could well be taking place, whereby those betting on the share price going down are forced into the market to buy shares to cover their positions.
A potential deal with�Morrison Supermarkets� (LSE: MRW ) also seems to be driving excitement right now. Yesterday, Morrisons said it plans to launch its online service by January, and reconfirmed that it was in discussions with Ocado about this. However, Morrisons was also at pains to point that its plans were not dependent on Ocado.
Best Safest Companies To Invest In Right Now: Biodel Inc (BIOD)
Biodel Inc. (Biodel), incorporated on December 3, 2003, is a development-stage speciality biopharmaceutical company focused on the development and commercialization of treatments for diabetes. The Company develops its product candidates by applying its formulation technologies to existing drugs. Its advanced program involves developing formulations of injectable recombinant human insulin (RHI). In addition to its ultra-rapid-acting insulin formulations, the Company has developed prototype formulations of a liquid glucagon, a basal insulin and a glucose responsive insulin, in each case for use by patients with diabetes. RHI-based formulation known as Linjeta was the subject of a New Drug Application (NDA).
The Company has two pivotal Phase III clinical trials with its preferred commercial formulation of Linjeta prior to re-submitting the NDA. In August 2011, it completed patient visits and analyzed top-line data from the first Phase 1 clinical trial of two RHI-based formulations. The trial was a single-center, randomized, double-blind, three-period crossover trial in 18 subjects with Type 1 diabetes. The purpose of the trial was to evaluate the pharmacokinetic and pharmacodynamic characteristics and injection site toleration of BIOD-105 and BIOD-107, as compared to the insulin analog marketed as Humalog. The Company conducted Phase I, Phase II and Phase III clinical trials comparing the performance of its Linjeta formulation of RHI to either Humulin, which is a branded formulation of RHI or Humalog. Its pivotal Phase III clinical trials were open-label, parallel group, randomized trials conducted at centers in the United States, Germany and India.
The Company competes with Eli Lilly, Novo Nordisk, Sanofi-Aventis, Halozyme Therapeutics, Inc. and MannKind Corporation.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 specialty biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Biodel (BIOD), which is focused on the development and commercialization of innovative treatments for diabetes. This stock has been hit hard by the bears over the last three months, with shares down by 24%.
If you take a look at the chart for Biodel, you'll notice that this stock is ripping higher here right off its 50-day moving average of $2.32 a share with strong upside volume. Volume on Thursday has so far registered over 750,000 shares, which is well above its three-month average action of 445,084 shares. This move is quickly pushing shares of BIOD within range of triggering a big breakout trade.
Traders should now look for long-biased trades in BIOD if it manages to break out above some near-term overhead resistance levels at $2.52 to $2.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 445,084 shares. If that breakout triggers soon, then BIOD will set up to re-test or possibly take out its next major overhead resistance levels $3 to its 200-day moving average of $3.39 a share. Any high-volume move above $3.39 will then give BIOD a chance to tag $4 a share.
Traders can look to buy BIOD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $2.10 a share. One can also buy BIOD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Supermarket Stocks To Buy Right Now: Vimicro International Corporation(VIMC)
Vimicro International Corporation, through its subsidiaries, designs, develops, and markets mixed-signal semiconductor products and system-level solutions for the consumer electronics, communications, and surveillance markets in Mainland China, Taiwan, Japan, Korea, and Hong Kong. It provides mixed-signal multimedia processors for personal computer and embedded notebook cameras, as well as for mobile phones. The company also offers system-level solutions that include integrated semiconductors, customizable firmware and software, software development tools, reference designs, and applications support. In addition, it provides security and surveillance products comprising video capturing, compression, transmission, storage, processing, display, and video analysis products. Further, the company involves in packaging, testing, and reselling third party image sensors. It sells its multimedia processor products through direct sales force and distributors to original design manuf acturers, original equipment manufacturers, design houses, and module manufacturers, as well as its security and surveillance products to government entities, telecommunications operators, schools, banks, railway companies, supermarkets, and theaters. The company was founded in 1999 and is based in Beijing, the People?s Republic of China.
Advisors' Opinion:- [By John Udovich]
Small cap security and surveillance stocks like Vimicro International Corporation (NASDAQ: VIMC), TASER International, Inc (NASDAQ: TASR), Kratos Defense & Security Solutions, Inc (NASDAQ: KTOS)�and View Systems Inc (OTCBB: VSYM) have been producing a steady stream of news lately for investors and traders alike to digest. After all, the entire�security and surveillance industry is pretty vast as it would include everything from airport scanners to security cameras or monitoring equipment to actual weapons for domestic or national defense to software securing everyone�� personal or online data to the technology groups like the NSA and other "Big Brother" agencies use to spy on us. With that in mind, here is a look at the latest news from important small cap security and surveillance stocks:
Best Supermarket Stocks To Buy Right Now: France Telecom S.A.(FTE)
France Telecom provides fixed telephony and mobile telecommunications, data transmission, Internet and multimedia, and other value-added services to consumers, businesses, and telecommunications operators. It also offers personal and home communication services, business network services, international carriers and shared services, and integration and outsourcing services for communication applications. The company operates in France, Spain, Poland, the United Kingdom, and internationally. France Telecom was founded in 1990 and is based in Paris, France.
Advisors' Opinion:- [By Sofia Horta e Costa]
Barclays Plc (BARC) fell to a one-month low as Sumitomo Mitsui Banking Corp. sold a stake in the lender. Fiat SpA lost 6.5 percent as Chrysler Group LLC went in for a vehicle recall. France Telecom SA (FTE) rose after its Orange Business Services unit won a five-year deal to deploy a private network for Heineken NV. Johnson Matthey Plc (JMAT) jumped to its highest price in at least 23 years after posting full-year profit that beat estimates.
Best Supermarket Stocks To Buy Right Now: Elite Pharmaceuticals Inc (ELTP)
Elite Pharmaceuticals, Inc. (Elite), incorporated on October 1, 1997, is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals. Elite has four products: Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets, Lodrane D Immediate Release capsules and Hydromorphone Hydrochloride 8 milligram tablets. During the fiscal years ended March 31, 2012 (Fiscal 2011), the Company manufactured and sold Lodrane 24 and Lodrane 24D (the Lodrane Extended Release Products).
The Company has a pipeline of additional generic drug candidates under active development, including, without limitation, ELI-154, a once-a-day oxycodone product and ELI-216, an abuse resistant oxycodone product which utilizes the Company�� propriety formulation for abuse resistant products utilizing the pharmacological approach (Elite�� Abuse Resistant Technology). ECR Pharmaceuticals (ECR), a wholly owned subsidiary of Hi-Tech Pharmacal, Inc. and the owner and marketer of the Lodrane Extended Release Products. Elite also purchased from Mikah Pharma LLC, an approved Abbreviated New Drug Application (ANDA) for Naltrexone 50 milligram tablets.
For ELI-154, Elite has developed a once-daily oxycodone formulation using its technology. An investigational new drug application (IND) has been filed and Elite has completed two pharmacokinetic studies in healthy subjects that compared blood levels of oxycodone from dosing ELI-154 and the twice-a-day product that is on the market, OxyContin marketed in the United States by Purdue Pharma LP. ELI-216 utilizes the Company's abuse-deterrent technology that is based on a pharmacological approach. ELI-216 is a combination of a narcotic agonist, oxycodone hydrochloride, in a sustained-release formulation intended for use in patients with moderate to severe chronic pain, and an antagonist, naltrexone hydrochloride, formulat! ed to deter abuse of the drug. Products utilizing the pharmacological approach to deter abuse such as Suboxone, a product marketed in the United States by Reckitt Benckiser Pharmaceuticals, Inc., and Embeda, a product marketed in the United States by Pfizer, have been approved by the United States Food & Drug Administration (FDA). ELI-216 demonstrates a euphoria-blocking effect when the product is crushed. Elite has developed ELI-154 and ELI-216 and retains the rights to these products.
The Company competes with Collegium Pharmaceuticals, Inc., Purdue Pharma LP, Acura Pharmaceuticals, Inc., Durect Corporation, Mylan Laboratories, Inc., Par Pharmaceuticals, Inc., Alkermes, Inc., Teva Pharmaceuticals Industries Ltd., Aptalis Pharma, Impax Laboratories, Inc., and Watson Pharmaceuticals.
Advisors' Opinion:- [By CRWE]
Today, ELTP has shed (-8.01%) down -0.009 at $.101 with 4,629,899 shares in play thus far (ref. google finance Delayed: 1:00PM EDT September 16, 2013).
Elite Pharmaceuticals, Inc. previously reported the first quarter of fiscal year 2014 ended June 30, 2013. Manufacturing and profit split revenues comprised almost all of Elite’s quarterly revenues and totaled $717k for the quarter, an increase of 41% from the prior year. This growth is attributed to the launch of two new products during the quarter, Phentermine 15mg and 30mg capsules, combined with strong year-on-year growth of the Elite’s Hydromorphone 8mg tablets and contract manufactured Methadone 10mg product lines.
- [By James E. Brumley]
Judging from the company it's keeping Green Automotive Co. (OTCMKTS:GACR) may have just made its way into the upper echelon of small cap stock opportunities. The electric car company joins Elite Pharmaceuticals Inc. (OTCBB:ELTP), Amarantus Bioscience Holdings, Inc. (OTCBB:AMBS), and only three other companies as Wall-Street.com's "Best 6 Stocks" for January of 2014. As one of the top information resources for investors - particularly in terms of information regarding small and micro cap stocks - being named among the site's top pick is an accolade for AMBS, ELTP, and GACR. Even more impressive is that Green Automotive Co. was the only consumer-goods name among those six. Amarantus Bioscience Holdings and Elite Pharmaceuticals are biotechnology names... an industry that can and often does attract a lot of attention just by the nature of the business. The other three names making the "Best 6" list were an energy explorer, a power-management technology manufacturer, and prescription/medical food producer. For an electric car manufacturer to make the list speaks quite highly of GACR.
- [By James E. Brumley]
Exactly one month ago today I penned some bullish thoughts on Elite Pharmaceuticals Inc. (OTCBB:ELTP). If you're familiar with the company - or a regular reader of this site - then you may know why that sounds a little "off." See, at the time, ELTP shares were falling rather quickly, giving up all the gains they had made just a few days before. Almost needless to say, my premise was not a well received one. Let's just say I received some "colorful disagreements" by being optimistic about the biopharma company.
Best Supermarket Stocks To Buy Right Now: InterOil Corp (IOC)
InterOil Corporation (InterOil), incorporated on August 24, 2007, is an integrated energy company operating in Papua New Guinea and the surrounding Southwest Pacific region. InterOil operates in four segments: upstream, midstream, downstream and corporate. The upstream segment explores, appraises and develops crude oil and natural gas structures in Papua New Guinea. This segment also manages its construction business, which services the development projects underway in Papua New Guinea. The midstream segment produces refined petroleum products at Napa Napa in Port Moresby, Papua New Guinea for the domestic market and for export. It is developing liquefaction and associated facilities in Papua New Guinea for the export of liquefied natural gas (LNG). The downstream segment markets and distributes refined products domestically in Papua New Guinea on a wholesale and retail basis.
During 2012, it sold approximately 13% of its refined petroleum products to Pacific Energy Aviation (PNG) Ltd for aviation refueling at Papua New Guinea�� international airport in Port Moresby. The corporate segment provides support to the other business segments by engaging in business development and improvement activities and providing general and administrative services and management, undertakes financing and treasury activities, and is responsible for government and investor relations. This segment also manages the Company�� shipping business, which operates two vessels transporting petroleum products for it�� and external customers, both within PNG and for export in the South Pacific region.
Upstream - Exploration and Production
InterOil�� upstream business segment focuses on the development program for the Elk, Antelope and Triceratops fields. The Elk and Antelope fields are onshore gas fields with contingent resources. As at December 31, 2012, it had interests in three PPLs and one PRL in Papua New Guinea covering 3,996,453 gross acres, all of which were operated by the Co! mpany. PPLs 236, 237 and 238 and PRL 15 are located onshore in the Eastern Papuan Basin, northwest of Port Moresby. It undertook exploration activities in its three exploration licenses, PPL 236, PPL 237 and PPL 238. These exploration activities involved a regional airborne geophysical survey, various seismic surveys across a number of prospects and preparation for drilling of its next appraisal well, Triceratops 2, which was spudded in mid-January 2012.
As of December 31, 2012, the Company had a 100% working interest in PPL 236. The license consists of 53 graticular blocks covering an area of 4,502 square kilometers or 1,112,464 acres. As of December 31, 2012, the Company had a 100% working interest in PPL 237. The license consists of 34 graticular blocks covering an area of 3,238 square kilometers or 715,648 acres. As of December 31, 2012, the Company had a 100% working interest in PPL 238. The license consists of 94 graticular blocks covering an area of 7,922 square kilometers or 1,978,565 acres.
Midstream
The Company�� refinery is located across the harbor from Port Moresby, the capital city of Papua New Guinea. Its refinery is the sole refiner of hydrocarbons located in Papua New Guinea. Jet fuel, diesel and gasoline are the primary products that the Company produces for the domestic market. The refining process also results in the production of two Naphtha grades and low sulfur waxy residue. Papua New Guinea is its principal market for the products its refinery produces, other than Naphtha and LSWR. Its refinery is fully certified to manufacture and market Jet A-1 fuel to international specifications and markets this product to both domestic Papua New Guinea and overseas airlines.
Downstream - Wholesale and Retail Distribution
The Company has the wholesale and retail petroleum product distribution base in Papua New Guinea. This business includes bulk storage, transportation distribution, aviation, wholesale and retail facilities! for refi! ned petroleum products. Its downstream business supplies petroleum products nationally in Papua New Guinea through a portfolio of retail service stations and commercial customers. As of December 31, 2012, InterOil provided petroleum products to 53 retail service stations with 43 operating under the InterOil brand name and the remaining 10 operating under their own independent brand. Of the 53 service stations that the Company supplies, 16 are either owned by or head leased to it, which it then sublease to company-approved operators. The remaining 37 service stations are independently owned and operated. It also provides fuel pumps and related infrastructure to the operators of the majority of these retail service stations that are not owned or leased by the Company under cover of equipment loan agreement. Its retail business accounted for approximately 15% of its total downstream sales during 2012. Its retail and wholesale distribution business distributes diesel, jet fuel, avgas, gasoline, kerosene and fuel oil, as well as branded commercial and industrial lubricants, such as engine and hydraulic oils.
The Company competes with ExxonMobil.
Advisors' Opinion:- [By John Del, Vecchio,]
As energy takes on more of a global focus, so do the stocks of the companies that produce it. With the increase in hydraulic fracturing, or fracking, places once thought of as flyover states are now booming industrial areas because of the new ability to uncover deep underground stores of oil and natural gas. There's a lot of room for excavation and discovery in these areas, and companies such as Chesapeake Energy (NYSE: CHK ) , WPX Energy (NYSE: WPX ) , and InterOil (NYSE: IOC ) are taking full advantage.
- [By Dan Caplinger]
Next Monday, InterOil (NYSE: IOC ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.
Best Supermarket Stocks To Buy Right Now: ViewPoint Financial Group Inc.(VPFG)
ViewPoint Financial Group, Inc. operates as the holding company for ViewPoint Bank, which provides financial services for consumers and businesses. Its deposit products include checking, savings, money market, demand accounts, and certificates of deposit. The company?s loan portfolio comprises real estate loans, such as one-to four-family, commercial construction, and home equity loans, as well as commercial real estate loans for office buildings, retail centers, light industrial facilities, warehouses, and multifamily properties; consumer loans, including new and used automobile loans, recreational vehicle loans, loans secured by savings deposits, and unsecured consumer loans; and commercial non-mortgage loans, including loans to finance business working capital, commercial vehicles, and equipment, as well as lines of credit. It also offers brokerage services for the purchase and sale of non-deposit investment and insurance products through a third party brokerage arrang ement. As of March 31, 2011, the company operated 23 community bank offices in the Dallas/Fort Worth Metroplex and 13 loan production offices located in Texas, Oklahoma, and Ohio. ViewPoint Financial Group, Inc. is headquartered in Plano, Texas.
Advisors' Opinion:- [By Rich Smith]
Plano, Texas-based ViewPoint Financial Group (NASDAQ: VPFG ) is looking for a new CFO.
On Wednesday, just before investors packed their bags for the holiday, ViewPoint announced that Chief Financial Officer Pathie E. McKee�intends to resign from the bank holding company at the end of this month. She will continue assisting ViewPoint in the capacity of a consultant through the end of the year, however, helping to ensure a smooth transition for her replacement.
No comments:
Post a Comment